Literature DB >> 14499739

Investigation of the normal proximal somatomotor system using magnetoencephalography.

Julia M Stephen1, Larry E Davis, Cheryl J Aine, Doug Ranken, Mark Herman, David Hudson, Mingxiong Huang, Janet Poole.   

Abstract

OBJECTIVE: The role of the ipsilateral cortex in proximal muscle control in normal human subjects is still under debate. One clinical finding, rapid recovery of proximal muscle relative to distal muscle use following stroke, has led to the suggestion that the ipsilateral as well as the contralateral motor cortex may be involved in normal proximal muscle control. The primary goal of this project was to identify contralateral and ipsilateral motor cortex activation associated with proximal muscle movement in normal subjects using magnetoencephalography (MEG).
METHODS: We developed protocols for a self-paced bicep motor task and a deltoid, electrical-stimulation somatosensory task. The MEG data were analyzed using automated multi-dipole spatiotemporal modeling techniques to localize the sources and characterize the associated timing of these sources.
RESULTS: Reliable contralateral primary motor and somatosensory sources localized to areas consistent with the homunculus. Ipsilateral M1 activation was only found in 2/12 hemispheres.
CONCLUSIONS: Robust contralateral motor cortex activation and sparse ipsilateral motor cortex activation suggest that the ipsilateral motor cortex is not involved in normal proximal muscle control. SIGNIFICANCE: The results suggest that proximal and distal muscle control is similar in normal subjects in the sense that proximal muscle control is primarily governed by the contralateral motor cortex.

Entities:  

Mesh:

Year:  2003        PMID: 14499739     DOI: 10.1016/s1388-2457(03)00150-0

Source DB:  PubMed          Journal:  Clin Neurophysiol        ISSN: 1388-2457            Impact factor:   3.708


  6 in total

1.  Amplitude by Peak Interaction but No Evidence of Auditory Mismatch Response Deficits to Frequency Change in Preschool-Aged Children with Fetal Alcohol Spectrum Disorders.

Authors:  Danielle M Kabella; Lucinda Flynn; Amanda Peters; Piyadasa Kodituwakku; Julia M Stephen
Journal:  Alcohol Clin Exp Res       Date:  2018-05-24       Impact factor: 3.455

2.  MEG source imaging method using fast L1 minimum-norm and its applications to signals with brain noise and human resting-state source amplitude images.

Authors:  Ming-Xiong Huang; Charles W Huang; Ashley Robb; AnneMarie Angeles; Sharon L Nichols; Dewleen G Baker; Tao Song; Deborah L Harrington; Rebecca J Theilmann; Ramesh Srinivasan; David Heister; Mithun Diwakar; Jose M Canive; J Christopher Edgar; Yu-Han Chen; Zhengwei Ji; Max Shen; Fady El-Gabalawy; Michael Levy; Robert McLay; Jennifer Webb-Murphy; Thomas T Liu; Angela Drake; Roland R Lee
Journal:  Neuroimage       Date:  2013-09-19       Impact factor: 6.556

3.  Delays in auditory processing identified in preschool children with FASD.

Authors:  Julia M Stephen; Piyadasa W Kodituwakku; Elizabeth L Kodituwakku; Lucinda Romero; Amanda M Peters; Nirupama M Sharadamma; Arvind Caprihan; Brian A Coffman
Journal:  Alcohol Clin Exp Res       Date:  2012-03-28       Impact factor: 3.455

4.  Somatosensory responses in normal aging, mild cognitive impairment, and Alzheimer's disease.

Authors:  Julia M Stephen; Rebecca Montaño; Christopher H Donahue; John C Adair; Janice Knoefel; Clifford Qualls; Blaine Hart; Doug Ranken; Cheryl J Aine
Journal:  J Neural Transm (Vienna)       Date:  2009-12-15       Impact factor: 3.575

5.  MEG-SIM: a web portal for testing MEG analysis methods using realistic simulated and empirical data.

Authors:  C J Aine; L Sanfratello; D Ranken; E Best; J A MacArthur; T Wallace; K Gilliam; C H Donahue; R Montaño; J E Bryant; A Scott; J M Stephen
Journal:  Neuroinformatics       Date:  2012-04

Review 6.  A scoping review of the contralateral effects of unilateral peripheral stimulation on neuromuscular function.

Authors:  Shi Zhou; Shuang-Shuang Zhang; Zachary J Crowley-McHattan
Journal:  PLoS One       Date:  2022-02-09       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.